Francesco Medici

TRISOMY 21: development of syndrome-specific growth charts from a wide Italian cohort and validation of BMI as a predictor of increased risk of metabolic derangement

Alessandro Cattoni, Silvia Molinari, Luisa Calì, Benedetta Riva et autres

it (code pays fourni par la source)

Diabetic cardiomyopathy: an educational review

Su-Lee Xiao, Emilia A. Bober, Xenophon Kassianides, Francesco Medici et autres

This educational review provides information about the epidemiology of diabetes and heart failure (diabetic cardiomyopathy) and the challenges in diagnosis and screening. Details on how to investigate patients with imaging and other modalities are discussed, as well as an update regarding the …

gb (code pays fourni par la source)

From Survey Results to a Decision-Making Matrix for Strategic Planning in Healthcare: The Case of Clinical Pathways

Lavinia Bianco, Salvatore Raffa, Paolo Fornelli, Rita Mancini et autres

BACKGROUND: It is a well-known fact that the information obtained from a survey can be used in a healthcare organizational analysis; however, it is very difficult to compare the different results found in the literature to each other, even through the use …

it (code pays fourni par la source)

Tan et al Clin Endocrinol 2009

Tricia Tan, Carmela Caputo, Francesco Medici, Alidz Pambakian et autres

Autoimmune markers and neurological complications in non-insulin-dependent diabetes mellitus

Susanna Morano, Claudio Tiberti, Giuseppe Cristina, Maurizio Sensi et autres

it (code pays fourni par la source)

High glucose modifies heparansulphate synthesis by mouse glomerular epithelial cells

Susanna Morano, Leo Guidobaldi, Annarita Gabriele, Federico Pantellini et autres

BACKGROUND: Alterations in proteoglycan metabolism are involved in the pathogenesis of diabetic nephropathy. The aim of this study is to evaluate the effects of high glucose on proteoglycan production and to find a reliable in vitro model for the study of diabetic …

it (code pays fourni par la source)

Perspectives in the Treatment of Dyslipidemias in the Prevention of Coronary Heart Disease

Maria Clotilde Borgia, Francesco Medici

In this review the indications for the available treatments for dyslipidemias in the prevention of coronary heart disease (CHD) are considered, and their efficacy according to the latest studies is analyzed. As data sources the authors used the main multicenter studies performed …

it (code pays fourni par la source)